Johnson & Johnson earnings came in 3% higher than consensus. The company’s operating leverage was “slightly diluted by higher tax.”
Latest Ratings for JNJ
DateFirmActionFromTo Jan 2022Raymond JamesMaintainsOutperform Jan 2022Morgan StanleyMaintainsEqual-Weight Dec 2021Goldman SachsInitiates Coverage OnNeutral